$HTGC News

Hercules Capital: Portfolio Metrics Warrant An Upgrade To Buy

Hercules Capital: 0.1% Non-Accruals, 125% Coverage, Top BDC Value

Hercules Capital: Net Asset Value And Dividend Coverage Expands

Hercules Capital: The Software Panic Was Overblown

Hercules Capital: Strong Growth But Valuation Leaves Little Room For Error

Ladenburg Thalmann Maintains Buy on Hercules Capital, Lowers Price Target to $20

Hercules Capital (NYSE:HTGC) Posts Inline Q2 Results, Shares Rise Slightly

Hercules Capital Q2 EPS $0.50 Beats $0.49 Estimate, Sales $149.114M Beat $145.478M Estimate

Hercules Capital (HTGC) Stock Dips While Market Gains: Key Facts

How Investors May Respond To Hercules Capital (HTGC) ESOP Equity Shelf And Potential Dilution Risk

4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital

Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors

Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet

Hercules Capital: This 12% Yield Is My Top Pick For The Back Half

2 Reasons to Avoid HTGC and 1 Stock to Buy Instead

Hercules Capital Faces Its Own 12 Labors

Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

Hercules Capital (HTGC) Ascends While Market Falls: Some Facts to Note

Beren Therapeutics Secures $300M In Combined Financing With Hercules Capital To Support Investments In Commercial Readiness Activities For Adrabetadex Ahead Of November 17 PDUFA Target Action Date

Hercules Capital: Attractive Valuation And Growth Potential